Abstract
798TiP Stereotactic radiotherapy alone or followed by niraparib for oligometastases or oligoprogression in ovarian cancer following PARP inhibitor therapy: SOPRANO trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have